Medicine Description kemocarb 150 mg
kemocarb 150 mg vial is a medication that functions primarily as a platinum-based chemotherapeutic agent. Its active ingredient, carboplatin, exerts its effects by forming DNA cross-links, which impede the replication of cancer cells. This disruption in DNA synthesis ultimately leads to cell apoptosis, or programmed cell death. By targeting rapidly dividing cells, carboplatin effectively slows tumor growth and limits the spread of cancerous cells within the body. This targeted action helps to manage advanced-stage malignancies more effectively, often in conjunction with other chemotherapy agents, enhancing the overall treatment efficacy.
Indications and Uses of kemocarb 150 mg vial
- Treatment of advanced ovarian cancer
- Management of small cell lung cancer
- Therapy for testicular cancer
- Used in combination regimens for various other solid tumors
Side Effects of kemocarb 150 mg vial
- Nausea and vomiting
- Bone marrow suppression, leading to anemia, leukopenia, or thrombocytopenia
- Fatigue
- Loss of appetite
- Peripheral neuropathy
- Hypersensitivity reactions
- Kidney function impairment
Storage and Handling
Store kemocarb 150 mg vial in a cool, dry place at controlled room temperature, away from light and moisture. Keep out of reach of children, and do not freeze. Once reconstituted, it should be used immediately or stored as directed by a healthcare professional.
Patient Advice and Precautions
Patients should be closely monitored throughout treatment with kemocarb. It is essential to maintain regular follow-up appointments to assess blood counts and kidney function. Hydration before and after administration may help mitigate some side effects. Notify your healthcare provider immediately if you experience severe nausea, unusual bleeding, or signs of infection. Discuss potential interactions with other medications with your healthcare provider, and adhere strictly to the prescribed treatment protocol.